Here are four things to know:
1. The study will test a new anti-inflammatory drug, designed to subdue tissue damage within hours of injury.
2. Already tested in animals, the intravenous immunoglobulin therapy decreased inflammation and enhanced spinal cord injury recovery.
3. Researchers plan to conduct the trial for three years with a total of 20 participants.
4. Princess Alexandra Hospital serves as the University of Queensland’s spinal injury care center.
More articles on spine:
How 6 spine surgeons managed (and are managing) their debt
Neurosurgeon Dr. Patrick Senatus highlighted in The Leading Physicians of the World: 8 points
8 things for spine surgeons to know for Thursday — Jan. 19, 2017
